Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Biljana Naumovic, Worldwide Vice President, Oncology, and Peter Lebowitz, Global Therapeutic Head, Oncology, will represent the Company in a session scheduled at 4:20 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  263.04
+3.34 (1.29%)
AAPL  270.17
-0.54 (-0.20%)
AMD  337.11
+13.90 (4.30%)
BAC  52.88
+0.22 (0.42%)
GOOG  347.31
-0.19 (-0.05%)
META  669.12
-2.22 (-0.33%)
MSFT  424.46
-4.79 (-1.12%)
NVDA  209.25
-3.92 (-1.84%)
ORCL  163.83
-2.13 (-1.28%)
TSLA  372.80
-3.22 (-0.86%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.